Global Oral GLP-1 Drug Market Growth (Status and Outlook) 2026-2032

July 2026 | 74 pages | ID: G677071A1326EN
LP Information

Abstracts

The global Oral GLP-1 Drug market size is predicted to grow from US$ 1475 million in 2025 to US$ 3156 million in 2032; it is expected to grow at a CAGR of 12.4% from 2026 to 2032.

Oral GLP-1 drugs are tablet-based incretin therapies that activate the GLP-1 receptor to reduce appetite, improve satiety and support long-term weight reduction without injection. Compared with injectable GLP-1 products, oral drugs may expand access among needle-averse patients and primary-care users, but their commercial success depends on efficacy, gastrointestinal tolerability, dosing restrictions, reimbursement and large-scale API/formulation capacity. In 2025, Global oral GLP-1 drug sales were still in an early launch stage, with a gross margin range of 70%?85%. The chain covers peptide or small-molecule API synthesis, absorption-enhancing formulation technology, tablet manufacturing, clinical development, regulatory approval, payer access and chronic obesity-care distribution.

Growth is supported by the large untreated obesity population, patient preference for non-injectable therapy, payer interest in broader but potentially more manageable access models, and pharmaceutical companies? efforts to extend GLP-1 treatment from specialist injection channels into primary care. Oral products also create a new segmentation layer in the obesity market because convenience, food restrictions, price and efficacy can be balanced differently from weekly injections.

LPI (LP Information)' newest research report, the ?Oral GLP-1 Drug Industry Forecast? looks at past sales and reviews total world Oral GLP-1 Drug sales in 2025, providing a comprehensive analysis by region and market sector of projected Oral GLP-1 Drug sales for 2026 through 2032. With Oral GLP-1 Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Oral GLP-1 Drug industry.

This Insight Report provides a comprehensive analysis of the global Oral GLP-1 Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Oral GLP-1 Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Oral GLP-1 Drug market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Oral GLP-1 Drug and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Oral GLP-1 Drug.

This report presents a comprehensive overview, market shares, and growth opportunities of Oral GLP-1 Drug market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Oral Peptide GLP-1
• Oral Small-Molecule GLP-1

Segmentation by Indication Status:

• Approved for Obesity
• Approved for Diabetes Only

Segmentation by Channel:

• Retail Pharmacy
• Direct-to-Consumer Pharmacy
• Hospital

Segmentation by Application:

• Obesity Care
• Diabetes Care
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Novo Nordisk
• Eli Lilly and Company

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Oral GLP-1 Drug Market Size (2021-2032)
  2.1.2 Oral GLP-1 Drug Market Size CAGR by Region (2021 VS 2025 VS 2032)
  2.1.3 World Current & Future Analysis for Oral GLP-1 Drug by Country/Region (2021, 2025 & 2032)
2.2 Oral GLP-1 Drug Segment by Type
  2.2.1 Oral Peptide GLP-1
  2.2.2 Oral Small-Molecule GLP-1
  2.2.3 Oral GLP-1 Drug Market Size by Type
    2.2.3.1 Oral GLP-1 Drug Market Size CAGR by Type (2021 VS 2025 VS 2032)
    2.2.3.2 Global Oral GLP-1 Drug Market Size Market Share by Type (2021-2026)
2.3 Oral GLP-1 Drug Segment by Indication Status
  2.3.1 Approved for Obesity
  2.3.2 Approved for Diabetes Only
  2.3.3 Oral GLP-1 Drug Market Size by Indication Status
    2.3.3.1 Oral GLP-1 Drug Market Size CAGR by Indication Status (2021 VS 2025 VS 2032)
    2.3.3.2 Global Oral GLP-1 Drug Market Size Market Share by Indication Status (2021-2026)
2.4 Oral GLP-1 Drug Segment by Channel
  2.4.1 Retail Pharmacy
  2.4.2 Direct-to-Consumer Pharmacy
  2.4.3 Hospital
  2.4.4 Oral GLP-1 Drug Market Size by Channel
    2.4.4.1 Oral GLP-1 Drug Market Size CAGR by Channel (2021 VS 2025 VS 2032)
    2.4.4.2 Global Oral GLP-1 Drug Market Size Market Share by Channel (2021-2026)
2.5 Oral GLP-1 Drug Segment by Application
  2.5.1 Obesity Care
  2.5.2 Diabetes Care
  2.5.3 Others
  2.5.4 Oral GLP-1 Drug Market Size by Application
    2.5.4.1 Oral GLP-1 Drug Market Size CAGR by Application (2021 VS 2025 VS 2032)
    2.5.4.2 Global Oral GLP-1 Drug Market Size Market Share by Application (2021-2026)

3 ORAL GLP-1 DRUG MARKET SIZE BY PLAYER

3.1 Oral GLP-1 Drug Market Size Market Share by Player
  3.1.1 Global Oral GLP-1 Drug Revenue by Player (2021-2026)
  3.1.2 Global Oral GLP-1 Drug Revenue Market Share by Player (2021-2026)
3.2 Global Oral GLP-1 Drug Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 ORAL GLP-1 DRUG BY REGION

4.1 Oral GLP-1 Drug Market Size by Region (2021-2026)
4.2 Global Oral GLP-1 Drug Annual Revenue by Country/Region (2021-2026)
4.3 Americas Oral GLP-1 Drug Market Size Growth (2021-2026)
4.4 APAC Oral GLP-1 Drug Market Size Growth (2021-2026)
4.5 Europe Oral GLP-1 Drug Market Size Growth (2021-2026)
4.6 Middle East & Africa Oral GLP-1 Drug Market Size Growth (2021-2026)

5 AMERICAS

5.1 Americas Oral GLP-1 Drug Market Size by Country (2021-2026)
5.2 Americas Oral GLP-1 Drug Market Size by Type (2021-2026)
5.3 Americas Oral GLP-1 Drug Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Oral GLP-1 Drug Market Size by Region (2021-2026)
6.2 APAC Oral GLP-1 Drug Market Size by Type (2021-2026)
6.3 APAC Oral GLP-1 Drug Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Oral GLP-1 Drug Market Size by Country (2021-2026)
7.2 Europe Oral GLP-1 Drug Market Size by Type (2021-2026)
7.3 Europe Oral GLP-1 Drug Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Oral GLP-1 Drug by Region (2021-2026)
8.2 Middle East & Africa Oral GLP-1 Drug Market Size by Type (2021-2026)
8.3 Middle East & Africa Oral GLP-1 Drug Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL ORAL GLP-1 DRUG MARKET FORECAST

10.1 Global Oral GLP-1 Drug Forecast by Region (2027-2032)
  10.1.1 Global Oral GLP-1 Drug Forecast by Region (2027-2032)
  10.1.2 Americas Oral GLP-1 Drug Forecast
  10.1.3 APAC Oral GLP-1 Drug Forecast
  10.1.4 Europe Oral GLP-1 Drug Forecast
  10.1.5 Middle East & Africa Oral GLP-1 Drug Forecast
10.2 Americas Oral GLP-1 Drug Forecast by Country (2027-2032)
  10.2.1 United States Market Oral GLP-1 Drug Forecast
  10.2.2 Canada Market Oral GLP-1 Drug Forecast
  10.2.3 Mexico Market Oral GLP-1 Drug Forecast
  10.2.4 Brazil Market Oral GLP-1 Drug Forecast
10.3 APAC Oral GLP-1 Drug Forecast by Region (2027-2032)
  10.3.1 China Oral GLP-1 Drug Market Forecast
  10.3.2 Japan Market Oral GLP-1 Drug Forecast
  10.3.3 Korea Market Oral GLP-1 Drug Forecast
  10.3.4 Southeast Asia Market Oral GLP-1 Drug Forecast
  10.3.5 India Market Oral GLP-1 Drug Forecast
  10.3.6 Australia Market Oral GLP-1 Drug Forecast
10.4 Europe Oral GLP-1 Drug Forecast by Country (2027-2032)
  10.4.1 Germany Market Oral GLP-1 Drug Forecast
  10.4.2 France Market Oral GLP-1 Drug Forecast
  10.4.3 UK Market Oral GLP-1 Drug Forecast
  10.4.4 Italy Market Oral GLP-1 Drug Forecast
  10.4.5 Russia Market Oral GLP-1 Drug Forecast
10.5 Middle East & Africa Oral GLP-1 Drug Forecast by Region (2027-2032)
  10.5.1 Egypt Market Oral GLP-1 Drug Forecast
  10.5.2 South Africa Market Oral GLP-1 Drug Forecast
  10.5.3 Israel Market Oral GLP-1 Drug Forecast
  10.5.4 Turkey Market Oral GLP-1 Drug Forecast
10.6 Global Oral GLP-1 Drug Forecast by Type (2027-2032)
10.7 Global Oral GLP-1 Drug Forecast by Application (2027-2032)
  10.7.1 GCC Countries Market Oral GLP-1 Drug Forecast

11 KEY PLAYERS ANALYSIS

11.1 Novo Nordisk
  11.1.1 Novo Nordisk Company Information
  11.1.2 Novo Nordisk Oral GLP-1 Drug Product Offered
  11.1.3 Novo Nordisk Oral GLP-1 Drug Revenue, Gross Margin and Market Share (2021-2026)
  11.1.4 Novo Nordisk Main Business Overview
  11.1.5 Novo Nordisk Latest Developments
11.2 Eli Lilly and Company
  11.2.1 Eli Lilly and Company Company Information
  11.2.2 Eli Lilly and Company Oral GLP-1 Drug Product Offered
  11.2.3 Eli Lilly and Company Oral GLP-1 Drug Revenue, Gross Margin and Market Share (2021-2026)
  11.2.4 Eli Lilly and Company Main Business Overview
  11.2.5 Eli Lilly and Company Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Oral GLP-1 Drug Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Oral GLP-1 Drug Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Oral Peptide GLP-1
Table 4. Major Players of Oral Small-Molecule GLP-1
Table 5. Oral GLP-1 Drug Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 6. Global Oral GLP-1 Drug Market Size by Type (2021-2026) & ($ millions)
Table 7. Global Oral GLP-1 Drug Market Size Market Share by Type (2021-2026)
Table 8. Major Players of Approved for Obesity
Table 9. Major Players of Approved for Diabetes Only
Table 10. Oral GLP-1 Drug Market Size CAGR by Indication Status (2021 VS 2025 VS 2032) & ($ millions)
Table 11. Global Oral GLP-1 Drug Market Size by Indication Status (2021-2026) & ($ millions)
Table 12. Global Oral GLP-1 Drug Market Size Market Share by Indication Status (2021-2026)
Table 13. Major Players of Retail Pharmacy
Table 14. Major Players of Direct-to-Consumer Pharmacy
Table 15. Major Players of Hospital
Table 16. Oral GLP-1 Drug Market Size CAGR by Channel (2021 VS 2025 VS 2032) & ($ millions)
Table 17. Global Oral GLP-1 Drug Market Size by Channel (2021-2026) & ($ millions)
Table 18. Global Oral GLP-1 Drug Market Size Market Share by Channel (2021-2026)
Table 19. Oral GLP-1 Drug Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 20. Global Oral GLP-1 Drug Market Size by Application (2021-2026) & ($ millions)
Table 21. Global Oral GLP-1 Drug Market Size Market Share by Application (2021-2026)
Table 22. Global Oral GLP-1 Drug Revenue by Player (2021-2026) & ($ millions)
Table 23. Global Oral GLP-1 Drug Revenue Market Share by Player (2021-2026)
Table 24. Oral GLP-1 Drug Key Players Head office and Products Offered
Table 25. Oral GLP-1 Drug Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 26. New Products and Potential Entrants
Table 27. Mergers & Acquisitions, Expansion
Table 28. Global Oral GLP-1 Drug Market Size by Region (2021-2026) & ($ millions)
Table 29. Global Oral GLP-1 Drug Market Size Market Share by Region (2021-2026)
Table 30. Global Oral GLP-1 Drug Revenue by Country/Region (2021-2026) & ($ millions)
Table 31. Global Oral GLP-1 Drug Revenue Market Share by Country/Region (2021-2026)
Table 32. Americas Oral GLP-1 Drug Market Size by Country (2021-2026) & ($ millions)
Table 33. Americas Oral GLP-1 Drug Market Size Market Share by Country (2021-2026)
Table 34. Americas Oral GLP-1 Drug Market Size by Type (2021-2026) & ($ millions)
Table 35. Americas Oral GLP-1 Drug Market Size Market Share by Type (2021-2026)
Table 36. Americas Oral GLP-1 Drug Market Size by Application (2021-2026) & ($ millions)
Table 37. Americas Oral GLP-1 Drug Market Size Market Share by Application (2021-2026)
Table 38. APAC Oral GLP-1 Drug Market Size by Region (2021-2026) & ($ millions)
Table 39. APAC Oral GLP-1 Drug Market Size Market Share by Region (2021-2026)
Table 40. APAC Oral GLP-1 Drug Market Size by Type (2021-2026) & ($ millions)
Table 41. APAC Oral GLP-1 Drug Market Size by Application (2021-2026) & ($ millions)
Table 42. Europe Oral GLP-1 Drug Market Size by Country (2021-2026) & ($ millions)
Table 43. Europe Oral GLP-1 Drug Market Size Market Share by Country (2021-2026)
Table 44. Europe Oral GLP-1 Drug Market Size by Type (2021-2026) & ($ millions)
Table 45. Europe Oral GLP-1 Drug Market Size by Application (2021-2026) & ($ millions)
Table 46. Middle East & Africa Oral GLP-1 Drug Market Size by Region (2021-2026) & ($ millions)
Table 47. Middle East & Africa Oral GLP-1 Drug Market Size by Type (2021-2026) & ($ millions)
Table 48. Middle East & Africa Oral GLP-1 Drug Market Size by Application (2021-2026) & ($ millions)
Table 49. Key Market Drivers & Growth Opportunities of Oral GLP-1 Drug
Table 50. Key Market Challenges & Risks of Oral GLP-1 Drug
Table 51. Key Industry Trends of Oral GLP-1 Drug
Table 52. Global Oral GLP-1 Drug Market Size Forecast by Region (2027-2032) & ($ millions)
Table 53. Global Oral GLP-1 Drug Market Size Market Share Forecast by Region (2027-2032)
Table 54. Global Oral GLP-1 Drug Market Size Forecast by Type (2027-2032) & ($ millions)
Table 55. Global Oral GLP-1 Drug Market Size Forecast by Application (2027-2032) & ($ millions)
Table 56. Novo Nordisk Details, Company Type, Oral GLP-1 Drug Area Served and Its Competitors
Table 57. Novo Nordisk Oral GLP-1 Drug Product Offered
Table 58. Novo Nordisk Oral GLP-1 Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 59. Novo Nordisk Main Business
Table 60. Novo Nordisk Latest Developments
Table 61. Eli Lilly and Company Details, Company Type, Oral GLP-1 Drug Area Served and Its Competitors
Table 62. Eli Lilly and Company Oral GLP-1 Drug Product Offered
Table 63. Eli Lilly and Company Oral GLP-1 Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 64. Eli Lilly and Company Main Business
Table 65. Eli Lilly and Company Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Oral GLP-1 Drug Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Oral GLP-1 Drug Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Oral GLP-1 Drug Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Oral GLP-1 Drug Sales Market Share by Country/Region (2025)
Figure 8. Oral GLP-1 Drug Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Oral GLP-1 Drug Market Size Market Share by Type in 2025
Figure 10. Global Oral GLP-1 Drug Market Size Market Share by Indication Status in 2025
Figure 11. Global Oral GLP-1 Drug Market Size Market Share by Channel in 2025
Figure 12. Oral GLP-1 Drug in Obesity Care
Figure 13. Global Oral GLP-1 Drug Market: Obesity Care (2021-2026) & ($ millions)
Figure 14. Oral GLP-1 Drug in Diabetes Care
Figure 15. Global Oral GLP-1 Drug Market: Diabetes Care (2021-2026) & ($ millions)
Figure 16. Oral GLP-1 Drug in Others
Figure 17. Global Oral GLP-1 Drug Market: Others (2021-2026) & ($ millions)
Figure 18. Global Oral GLP-1 Drug Market Size Market Share by Application in 2025
Figure 19. Global Oral GLP-1 Drug Revenue Market Share by Player in 2025
Figure 20. Global Oral GLP-1 Drug Market Size Market Share by Region (2021-2026)
Figure 21. Americas Oral GLP-1 Drug Market Size 2021-2026 ($ millions)
Figure 22. APAC Oral GLP-1 Drug Market Size 2021-2026 ($ millions)
Figure 23. Europe Oral GLP-1 Drug Market Size 2021-2026 ($ millions)
Figure 24. Middle East & Africa Oral GLP-1 Drug Market Size 2021-2026 ($ millions)
Figure 25. Americas Oral GLP-1 Drug Value Market Share by Country in 2025
Figure 26. United States Oral GLP-1 Drug Market Size Growth 2021-2026 ($ millions)
Figure 27. Canada Oral GLP-1 Drug Market Size Growth 2021-2026 ($ millions)
Figure 28. Mexico Oral GLP-1 Drug Market Size Growth 2021-2026 ($ millions)
Figure 29. Brazil Oral GLP-1 Drug Market Size Growth 2021-2026 ($ millions)
Figure 30. APAC Oral GLP-1 Drug Market Size Market Share by Region in 2025
Figure 31. APAC Oral GLP-1 Drug Market Size Market Share by Type (2021-2026)
Figure 32. APAC Oral GLP-1 Drug Market Size Market Share by Application (2021-2026)
Figure 33. China Oral GLP-1 Drug Market Size Growth 2021-2026 ($ millions)
Figure 34. Japan Oral GLP-1 Drug Market Size Growth 2021-2026 ($ millions)
Figure 35. South Korea Oral GLP-1 Drug Market Size Growth 2021-2026 ($ millions)
Figure 36. Southeast Asia Oral GLP-1 Drug Market Size Growth 2021-2026 ($ millions)
Figure 37. India Oral GLP-1 Drug Market Size Growth 2021-2026 ($ millions)
Figure 38. Australia Oral GLP-1 Drug Market Size Growth 2021-2026 ($ millions)
Figure 39. Europe Oral GLP-1 Drug Market Size Market Share by Country in 2025
Figure 40. Europe Oral GLP-1 Drug Market Size Market Share by Type (2021-2026)
Figure 41. Europe Oral GLP-1 Drug Market Size Market Share by Application (2021-2026)
Figure 42. Germany Oral GLP-1 Drug Market Size Growth 2021-2026 ($ millions)
Figure 43. France Oral GLP-1 Drug Market Size Growth 2021-2026 ($ millions)
Figure 44. UK Oral GLP-1 Drug Market Size Growth 2021-2026 ($ millions)
Figure 45. Italy Oral GLP-1 Drug Market Size Growth 2021-2026 ($ millions)
Figure 46. Russia Oral GLP-1 Drug Market Size Growth 2021-2026 ($ millions)
Figure 47. Middle East & Africa Oral GLP-1 Drug Market Size Market Share by Region (2021-2026)
Figure 48. Middle East & Africa Oral GLP-1 Drug Market Size Market Share by Type (2021-2026)
Figure 49. Middle East & Africa Oral GLP-1 Drug Market Size Market Share by Application (2021-2026)
Figure 50. Egypt Oral GLP-1 Drug Market Size Growth 2021-2026 ($ millions)
Figure 51. South Africa Oral GLP-1 Drug Market Size Growth 2021-2026 ($ millions)
Figure 52. Israel Oral GLP-1 Drug Market Size Growth 2021-2026 ($ millions)
Figure 53. Turkey Oral GLP-1 Drug Market Size Growth 2021-2026 ($ millions)
Figure 54. GCC Countries Oral GLP-1 Drug Market Size Growth 2021-2026 ($ millions)
Figure 55. Americas Oral GLP-1 Drug Market Size 2027-2032 ($ millions)
Figure 56. APAC Oral GLP-1 Drug Market Size 2027-2032 ($ millions)
Figure 57. Europe Oral GLP-1 Drug Market Size 2027-2032 ($ millions)
Figure 58. Middle East & Africa Oral GLP-1 Drug Market Size 2027-2032 ($ millions)
Figure 59. United States Oral GLP-1 Drug Market Size 2027-2032 ($ millions)
Figure 60. Canada Oral GLP-1 Drug Market Size 2027-2032 ($ millions)
Figure 61. Mexico Oral GLP-1 Drug Market Size 2027-2032 ($ millions)
Figure 62. Brazil Oral GLP-1 Drug Market Size 2027-2032 ($ millions)
Figure 63. China Oral GLP-1 Drug Market Size 2027-2032 ($ millions)
Figure 64. Japan Oral GLP-1 Drug Market Size 2027-2032 ($ millions)
Figure 65. Korea Oral GLP-1 Drug Market Size 2027-2032 ($ millions)
Figure 66. Southeast Asia Oral GLP-1 Drug Market Size 2027-2032 ($ millions)
Figure 67. India Oral GLP-1 Drug Market Size 2027-2032 ($ millions)
Figure 68. Australia Oral GLP-1 Drug Market Size 2027-2032 ($ millions)
Figure 69. Germany Oral GLP-1 Drug Market Size 2027-2032 ($ millions)
Figure 70. France Oral GLP-1 Drug Market Size 2027-2032 ($ millions)
Figure 71. UK Oral GLP-1 Drug Market Size 2027-2032 ($ millions)
Figure 72. Italy Oral GLP-1 Drug Market Size 2027-2032 ($ millions)
Figure 73. Russia Oral GLP-1 Drug Market Size 2027-2032 ($ millions)
Figure 74. Egypt Oral GLP-1 Drug Market Size 2027-2032 ($ millions)
Figure 75. South Africa Oral GLP-1 Drug Market Size 2027-2032 ($ millions)
Figure 76. Israel Oral GLP-1 Drug Market Size 2027-2032 ($ millions)
Figure 77. Turkey Oral GLP-1 Drug Market Size 2027-2032 ($ millions)
Figure 78. Global Oral GLP-1 Drug Market Size Market Share Forecast by Type (2027-2032)
Figure 79. Global Oral GLP-1 Drug Market Size Market Share Forecast by Application (2027-2032)
Figure 80. GCC Countries Oral GLP-1 Drug Market Size 2027-2032 ($ millions)